DANA-FARBER DIRECT CONNECT

Dana-Farber’s Direct Connect program offers patients in Bermuda direct and easy access to world-renowned cancer care.  Direct Connect supports the unique needs of your patients and their families through a dedicated phone line and email address staffed by a highly experienced patient liaison team. Our committed patient liaison team will connect patients with our oncology experts who treat their specific type of cancer. The Direct Connect team will facilitate an initial in-person appointment in collaboration with the International Patient Center and serves as the single point of entry to coordinate all oncology care across Dana-Farber.

Each year Dana-Farber welcomes thousands of adult and pediatric patients from over 120 countries who need advanced treatment and specialized expertise that is not available at home. Our staff, including oncology dedicated physicians, nurse navigators, medical interpreters, and patient program managers, specialize in coordinating all aspects of the international patient journey.

DANA-FARBER CANCER INSTITUTE

For over 70 years, Dana-Farber Cancer Institute has had one goal: to reduce the suffering caused by cancer through advanced clinical care and scientific research. Dana-Farber is committed to providing multidisciplinary, compassionate, and collaborative care that puts patients and their families at the center. Care is provided by teams of specialists organized around combating specific types of cancer and tailoring treatments for each individual patient. As a principal teaching affiliate of Harvard Medical School, Dana-Farber attracts many of the best and brightest physicians and researchers in the world to share in this mission.

Dana-Farber is a Magnet® organization, a designation that recognizes the Institute’s quality patient care, nursing excellence, and innovations in professional nursing practice. Dana-Farber’s expert clinical and support services teams strive to provide patients and their families with an excellent patient-centered experience and to maintain quality of life during and after treatment. When surveyed, over 96% of Dana-Farber patients were satisfied with the care they received at Dana-Farber, and 96.9% said they would recommend Dana-Farber.

Dana Farber is the only hospital in the United States with a top 5 U.S. News & World Report “Best Hospitals” ranking in both adult and pediatric cancer care. Dana-Farber Brigham Cancer Center brings together specialists from Dana-Farber Cancer Institute and Brigham and Women’s Hospital to treat adults with all types of cancer. The multidisciplinary teams include medical, radiation, and surgical oncologists along with radiology and pathology subspecialists in each type of cancer. They offer the latest treatments, many of which were pioneered at Dana-Farber, along with clinical trials for promising new therapies.

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center offers the combined expertise of Dana-Farber Cancer Institute and Boston Children’s Hospital, to provide seamless, integrated care for children with all types of cancer and blood disorders – including the rarest and most complex cases.

Adult treatment centers include:

• Breast Cancer
• Cancer Genetics & Prevention
• Cutaneous (skin) Cancer
• Gastrointestinal Cancer
• Genitourinary Cancer
• Gynecologic Cancer
• Head and Neck Cancer
• Hematologic Oncology
• Hematology
• Melanoma
• Neuro-Oncology
• Sarcoma & Bone Cancer
• Thoracic (Lung) Cancer

Care is also provided through the following specialty centers:

• Adolescent and Young Adult Neuro-Oncology Program
• Center for Cancer Therapeutic Innovation
• Center for Immuno0Oncology
• Fertility Preservation (Oncofertility) Programs
• Oral Medicine and Oral Oncology
• Palliative Care
• Psychosocial Oncology
• Stem Cell Transplantation and Cellular Therapies
• Survivorship Programs

Pediatric Treatment Centers include:

• Hematologic Malignancies
• Blood Disorders
• Solid Tumors
• Neuro-Oncology
• Stem Cell Transplant

CELLULAR THERAPIES

Dana-Farber has a long history utilizing cellular therapies to treat blood cancers and blood disorders. Over more than 30 years, we have performed more than 10,600 hematopoietic stem cell transplants, the original form of cellular therapy. We continue to offer patients the latest treatments, including CAR T-cell therapy, other genetically modified T cells, and cancer vaccines.

BENCH TO BEDSIDE: CANCER RESEARCH AND CARE

Dana-Farber Cancer Institute remains true to Dr. Sidney Farber's vision of a cancer center that is as dedicated to discoveries in cancer research as it is to delivering compassionate, patient-centered care. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a National Cancer Institute (NCI)-designated Comprehensive Cancer Center. Dana-Farber has the most highly cited research of any leading U.S. cancer center and is the top recipient of NCI funding and over the last ten years, approximately 1 in 4 of all FDA-approved cancer drugs in the U.S. were in part developed with Dana-Farber Cancer Institute.

The Institute is home to one of the nation’s most comprehensive precision cancer medicine research initiatives, having completed more than 50,000 genetic profiles of patients’ tumors and adding about 400 each month to the database. Clinicians use specialized tests to create a precise “tumor profile” of genetic changes for each patient’s cancer, making it possible to identify the most important mutations. Results from these tests can help in the selection of specific therapeutic agents to precisely treat each individual’s cancer.

Throughout its history, Dana-Farber has remained committed to providing patient-centered clinical care while further advancing innovation and discovery. We are pleased to provide our cutting-edge oncology care to patients in Bermuda through our Direct Connect Program. For additional information please contact the Dana-Farber Direct Connect team at DirectConnect@DFCI.HARVARD.EDU or 866-977-3262.